Laser-Sharp Research nomination goes to this month for Professor Kobayashi’s team and Dr. Noriko Sato’s team at National Cancer Institute, National Institute of Health, USA. Their research published in a prestigious Cancer Research journal showed that photoimmunotherapy can not only target tumor cells, but can also be harnessed to target body’s own tumor-promoting immune cells within the tumor. These special cells called intratumoral Tregs were selectively killed by photoimmunotherapy upon illumination with ML7710 laser, which led to activation of body’s own killer immune cells and growth suppression of the tumors in preclinical studies.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!#LaserSharpResearch #ModulightInScience #LasersInScience #ImmunoTherapy #NovelTreatments
Modulight products used:
About Modulight’s LASER-SHARP RESEARCH concept:
Modulight has launched a concept where our scientific board monthly highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that your would like us to spotlight? Or would you like to request literature? Please drop us a line!